These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2399934)

  • 1. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis.
    Doi T; Striker LJ; Gibson CC; Agodoa LY; Brinster RL; Striker GE
    Am J Pathol; 1990 Sep; 137(3):541-52. PubMed ID: 2399934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1.
    Doi T; Striker LJ; Quaife C; Conti FG; Palmiter R; Behringer R; Brinster R; Striker GE
    Am J Pathol; 1988 Jun; 131(3):398-403. PubMed ID: 3132856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice.
    Quaife CJ; Mathews LS; Pinkert CA; Hammer RE; Brinster RL; Palmiter RD
    Endocrinology; 1989 Jan; 124(1):40-8. PubMed ID: 2642417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice.
    Yang CW; Striker LJ; Pesce C; Chen WY; Peten EP; Elliot S; Doi T; Kopchick JJ; Striker GE
    Lab Invest; 1993 Jan; 68(1):62-70. PubMed ID: 8423678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene.
    Yang CW; Striker LJ; Kopchick JJ; Chen WY; Pesce CM; Peten EP; Striker GE
    Kidney Int Suppl; 1993 Jan; 39():S90-4. PubMed ID: 8468934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1.
    Doublier S; Seurin D; Fouqueray B; Verpont MC; Callard P; Striker LJ; Striker GE; Binoux M; Baud L
    Kidney Int; 2000 Jun; 57(6):2299-307. PubMed ID: 10844600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth.
    Blutke A; Schneider MR; Wolf E; Wanke R
    Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.
    Segev Y; Eshet R; Yakir O; Haim N; Phillip M; Landau D
    Diabetologia; 2007 Jun; 50(6):1327-34. PubMed ID: 17443310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice.
    Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA
    Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease.
    Flyvbjerg A; Landau D; Domene H; Hernandez L; Grønbaek H; LeRoith D
    Metabolism; 1995 Oct; 44(10 Suppl 4):67-71. PubMed ID: 7476314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of selective growth hormone defect in the progression of glomerulosclerosis.
    Yoshida H; Mitarai T; Kitamura M; Suzuki T; Ishikawa H; Fogo A; Sakai O
    Am J Kidney Dis; 1994 Feb; 23(2):302-12. PubMed ID: 8311091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
    Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
    Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice.
    Behringer RR; Lewin TM; Quaife CJ; Palmiter RD; Brinster RL; D'Ercole AJ
    Endocrinology; 1990 Sep; 127(3):1033-40. PubMed ID: 2387246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone.
    Pesce CM; Striker LJ; Peten E; Elliot SJ; Striker GE
    Lab Invest; 1991 Nov; 65(5):601-5. PubMed ID: 1753707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone-insulin-like growth factor axis in kidney.
    Hammerman MR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F503-14. PubMed ID: 2679142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological changes in the kidney of dogs chronically exposed to exogenous growth hormone.
    Molon-Noblot S; Laroque P; Prahalada S; Stabinski LG; Peter CP; Duprat P; van Zwieten MJ
    Toxicol Pathol; 2000; 28(4):510-7. PubMed ID: 10930036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.
    Kumar PA; Brosius FC; Menon RK
    Curr Diabetes Rev; 2011 Jan; 7(1):50-5. PubMed ID: 21067510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.
    Hoeflich A; Nedbal S; Blum WF; Erhard M; Lahm H; Brem G; Kolb HJ; Wanke R; Wolf E
    Endocrinology; 2001 May; 142(5):1889-98. PubMed ID: 11316754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
    Wanke R; Wolf E; Brem G; Hermanns W
    Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.